BCL2 and neoplasm: We observed a marked decrease in Bcl-2, Bcl-xL, Survivin, full-length PARP, and procaspase-3 (Figure 8C), thus indicating that Tris DBA can interfere with tumor development by inducing apoptosis in tumor cells.